Myasthenia gravis and specific immunotherapy: monoclonal antibodies-Reference-Cited by-同舟云学术

Myasthenia gravis and specific immunotherapy: monoclonal antibodies

Published:2019-08-08 Issue:1 Volume:1452 Page:18-33
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:Ann. N.Y. Acad. Sci.

Author:

Cai Xiao‐Jun¹²,Li Zai‐Wang³⁴,Xi Jian‐Ying⁵,Song Hui‐Zhu²,Liu Jue¹,Zhu Wen‐Hua⁵,Guo Yi³,Jiao Zheng¹

Affiliation:

1. Department of Clinical Pharmacy, Huashan HospitalFudan University Shanghai P. R. China

2. Department of Pharmacythe Affiliated Wuxi People's Hospital of Nanjing Medical University Wuxi P. R. China

3. Department of Neurology, Shenzhen People's Hospital, the Second Clinical Medical College of Jinan Universitythe First Affiliated Hospital of Southern University of Science and Technology Shenzhen P. R. China

4. Department of Neurologythe Affiliated Wuxi People's Hospital of Nanjing Medical University Wuxi P. R. China

5. Department of Neurology, Huashan HospitalFudan University Shanghai P. R. China

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nyas.14195

Reference102 articles.

1. Myasthenia gravis: the role of complement at the neuromuscular junction

2. Advances in autoimmune myasthenia gravis management

3. Myasthenia Gravis

4. Lifetime course of myasthenia gravis

5. When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective;Applied Health Economics and Health Policy;2024-07-13

2. Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities;Frontiers in Pharmacology;2024-05-27

3. Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients;Journal of Neuroimmunology;2024-02

4. Myasthenia gravis: Molecular mechanisms and promising therapeutic strategies;Biochemical Pharmacology;2023-12

5. Different Monoclonal Antibodies in Myasthenia Gravis: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-01-18